The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure ...

More than 580,000 blood pressure capsules have been recalled over cancer concerns. Here's how hypertension affects the Ohio ...

The FDA classified the recall as a Class II because the medication could contain nitrosamine impurities, a class of chemicals ...

The FDA says more than 580,000 bottles of a blood pressure medication have been recalled over concerns that it may contain a cancer-causing chemical.

Nearly 590,000 bottles of blood pressure drugs have been recalled over concerns that they may contain a potentially ...

The U.S. Food and Drug Administration (FDA) announced that more than 580,000 bottles of the blood pressure medication ...

More than half a million bottles of prazosin hydrochloride, a common blood pressure medication, have been recalled by Teva Pharmaceuticals after tests found traces of a possible cancer-causing ...

A New Jersey-based pharmaceutical company issued a voluntary recall for over half a million bottles of Prazosin Hydrochloride ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...

Novartis has forged an alliance with Microsoft that will apply artificial intelligence and machine-learning to the discovery, development and commercialisation of new medicines. The five-year deal to ...